Gyeonggi-do, South Korea

Kyung-Mi An




Average Co-Inventor Count = 9.3

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Gyeonggi-do, KR (2017 - 2022)
  • Gunpo-si, KR (2023)

Company Filing History:


Years Active: 2017-2023

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Inventor Kyung-Mi An

Introduction

Kyung-Mi An is a prominent inventor based in Gyeonggi-do, South Korea, known for her significant contributions to the pharmaceutical field. With a portfolio of five patents, her work primarily focuses on developing compounds aimed at treating conditions such as type 2 diabetes.

Latest Patents

One of her latest innovations includes the patent for phenyl propionic acid derivatives. These compounds, characterized by their ability to function as GPR40 agonists, play a crucial role in regulating blood glucose levels and enhancing glucose-dependent insulin secretion. This advancement offers a promising solution for the prevention and treatment of type 2 diabetes while minimizing the risk of hypoglycemia. Another notable patent involves phthalazinone derivatives, which encompass pharmaceutical compositions designed to inhibit the activity of the Poly(ADP-riboside) polymerase enzyme. These patents exemplify An's commitment to addressing critical health challenges through innovative solutions.

Career Highlights

Throughout her career, Kyung-Mi An has affiliated herself with respected pharmaceutical companies, such as Ildong Pharm Co., Ltd. and Il Dong Pharmaceutical Co., Ltd. Her experiences in these organizations have provided her with invaluable insight into the pharmaceutical industry, allowing her to develop and patent her breakthrough innovations.

Collaborations

In her journey as an inventor, Kyung-Mi An has collaborated with various professionals, including notable colleagues like Jae-Hoon Kang and Hong-Sub Lee. These collaborative efforts highlight the importance of teamwork in advancing scientific research and innovation.

Conclusion

Kyung-Mi An's contributions to pharmaceutical innovation are commendable, with her patents reflecting a profound understanding of biochemical processes and their implications for health. As she continues to develop new solutions, her work stands as a testament to the evolving landscape of medical science and its ability to improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…